In contrast to our initial expectations, the removal of IL-6Rα in myelomonocytic cells [17] had no effect on the severity of IMQ-induced psoriasis-like skin disease: The IL-6RαΔmyel mice presented the same PASI scores for skin thickness, erythema and scaling as the control animals under IMQ-treatment. This evidence concerns the gene IL6R and psoriasis.